Sarcoidosis is a multisystem, granulomatous disease that most often affects the lungs. The
clinical course is highly variable; many patients undergo spontaneous remission, but up to a …

Understanding the mechanisms of fibrotic transformation in sarcoidosis enhances clinical
care and facilitates development of novel therapeutic options. The impact of these findings in …

Sarcoidosis is an immune-mediated disorder. Its immunopathology has been steadily
mapped out over the past few decades. Despite this, the underpinning mechanisms for …

AIMS: Sarcoidosis is a granulomatous disease of unknown etiology marked by tremendous
clinical heterogeneity. Many patients enter remission with good long-term outcomes. Yet …

Sarcoidosis is a multisystem granulomatous disorder of unknown aetiology. A minority of
patients with sarcoidosis develop sarcoidosis-associated pulmonary fibrosis (SAPF), which …

Abstract Concepts regarding etiology and pathophysiology of sarcoidosis have changed
remarkably within the past 5 years. Sarcoidosis is now viewed as a complex multi-causation …

Thoracic sarcoidosis is the most common form of sarcoidosis, encompassing a
heterogeneous group of patients with a wide range of clinical features and associated …

Sarcoidosis is a systemic inflammatory disease with a predilection for the respiratory system.
Although most patients enter remission and have good long-term outcomes, up to 20 …

Introduction Advanced pulmonary sarcoidosis refers to phenotypes of pulmonary
sarcoidosis that often lead to significant loss of lung function, respiratory failure, or death …

Introduction: Most of the morbidity and mortality resulting from pulmonary sarcoidosis relates
to complications of fibrotic disease. Because the fibrosis related to pulmonary sarcoidosis is …